COVID-19 Impact on Global Influenza Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Influenza Therapeutics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Influenza Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Vaccines
  • 1.4.3 Drugs
• 1.5 Market by Application
  • 1.5.1 Global Influenza Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinic
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Influenza Therapeutics Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Influenza Therapeutics Industry
    • 1.6.1.1 Influenza Therapeutics Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Influenza Therapeutics Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Influenza Therapeutics Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Influenza Therapeutics Market Perspective (2015-2026)
• 2.2 Influenza Therapeutics Growth Trends by Regions
  • 2.2.1 Influenza Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Influenza Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Influenza Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Influenza Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Influenza Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Influenza Therapeutics Players by Market Size
  • 3.1.1 Global Top Influenza Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Influenza Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Influenza Therapeutics Market Concentration Ratio
  • 3.2.1 Global Influenza Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Influenza Therapeutics Revenue in 2019
• 3.3 Influenza Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Influenza Therapeutics Product Solution and Service
• 3.5 Date of Enter into Influenza Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Influenza Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Influenza Therapeutics Forecasted Market Size by Type (2021-2026)

5 Influenza Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Influenza Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Influenza Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Influenza Therapeutics Market Size (2015-2020)
• 6.2 Influenza Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Influenza Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Influenza Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Influenza Therapeutics Market Size (2015-2020)
• 7.2 Influenza Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Influenza Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Influenza Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Influenza Therapeutics Market Size (2015-2020)
• 8.2 Influenza Therapeutics Key Players in China (2019-2020)
• 8.3 China Influenza Therapeutics Market Size by Type (2015-2020)
• 8.4 China Influenza Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Influenza Therapeutics Market Size (2015-2020)
• 9.2 Influenza Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Influenza Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Influenza Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Influenza Therapeutics Market Size (2015-2020)
• 10.2 Influenza Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Influenza Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Influenza Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Influenza Therapeutics Market Size (2015-2020)
• 11.2 Influenza Therapeutics Key Players in India (2019-2020)
• 11.3 India Influenza Therapeutics Market Size by Type (2015-2020)
• 11.4 India Influenza Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Influenza Therapeutics Market Size (2015-2020)
• 12.2 Influenza Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Influenza Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Influenza Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Laboratories
  • 13.1.1 Abbott Laboratories Company Details
  • 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  • 13.1.3 Abbott Laboratories Influenza Therapeutics Introduction
  • 13.1.4 Abbott Laboratories Revenue in Influenza Therapeutics Business (2015-2020))
  • 13.1.5 Abbott Laboratories Recent Development
• 13.2 Astrazeneca PLC
  • 13.2.1 Astrazeneca PLC Company Details
  • 13.2.2 Astrazeneca PLC Business Overview and Its Total Revenue
  • 13.2.3 Astrazeneca PLC Influenza Therapeutics Introduction
  • 13.2.4 Astrazeneca PLC Revenue in Influenza Therapeutics Business (2015-2020)
  • 13.2.5 Astrazeneca PLC Recent Development
• 13.3 Biocryst Pharmaceuticals, Inc.
  • 13.3.1 Biocryst Pharmaceuticals, Inc. Company Details
  • 13.3.2 Biocryst Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  • 13.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Introduction
  • 13.3.4 Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2015-2020)
  • 13.3.5 Biocryst Pharmaceuticals, Inc. Recent Development
• 13.4 Chiron Corporation
  • 13.4.1 Chiron Corporation Company Details
  • 13.4.2 Chiron Corporation Business Overview and Its Total Revenue
  • 13.4.3 Chiron Corporation Influenza Therapeutics Introduction
  • 13.4.4 Chiron Corporation Revenue in Influenza Therapeutics Business (2015-2020)
  • 13.4.5 Chiron Corporation Recent Development
• 13.5 CSL Limited
  • 13.5.1 CSL Limited Company Details
  • 13.5.2 CSL Limited Business Overview and Its Total Revenue
  • 13.5.3 CSL Limited Influenza Therapeutics Introduction
  • 13.5.4 CSL Limited Revenue in Influenza Therapeutics Business (2015-2020)
  • 13.5.5 CSL Limited Recent Development
• 13.6 Daiichi Sankyo Co., Ltd.
  • 13.6.1 Daiichi Sankyo Co., Ltd. Company Details
  • 13.6.2 Daiichi Sankyo Co., Ltd. Business Overview and Its Total Revenue
  • 13.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Introduction
  • 13.6.4 Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
  • 13.6.5 Daiichi Sankyo Co., Ltd. Recent Development
• 13.7 Glaxosmithkline PLC
  • 13.7.1 Glaxosmithkline PLC Company Details
  • 13.7.2 Glaxosmithkline PLC Business Overview and Its Total Revenue
  • 13.7.3 Glaxosmithkline PLC Influenza Therapeutics Introduction
  • 13.7.4 Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2015-2020)
  • 13.7.5 Glaxosmithkline PLC Recent Development
• 13.8 Mitsubishi Tanabe Pharma Corporation
  • 13.8.1 Mitsubishi Tanabe Pharma Corporation Company Details
  • 13.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview and Its Total Revenue
  • 13.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Introduction
  • 13.8.4 Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2015-2020)
  • 13.8.5 Mitsubishi Tanabe Pharma Corporation Recent Development
• 13.9 Nanotherapeutics Inc.
  • 13.9.1 Nanotherapeutics Inc. Company Details
  • 13.9.2 Nanotherapeutics Inc. Business Overview and Its Total Revenue
  • 13.9.3 Nanotherapeutics Inc. Influenza Therapeutics Introduction
  • 13.9.4 Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2015-2020)
  • 13.9.5 Nanotherapeutics Inc. Recent Development
• 13.10 Protein Sciences Corporation
  • 13.10.1 Protein Sciences Corporation Company Details
  • 13.10.2 Protein Sciences Corporation Business Overview and Its Total Revenue
  • 13.10.3 Protein Sciences Corporation Influenza Therapeutics Introduction
  • 13.10.4 Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2015-2020)
  • 13.10.5 Protein Sciences Corporation Recent Development
• 13.11 Roche Holding AG
  • 10.11.1 Roche Holding AG Company Details
  • 10.11.2 Roche Holding AG Business Overview and Its Total Revenue
  • 10.11.3 Roche Holding AG Influenza Therapeutics Introduction
  • 10.11.4 Roche Holding AG Revenue in Influenza Therapeutics Business (2015-2020)
  • 10.11.5 Roche Holding AG Recent Development
• 13.12 Sanofi SA
  • 10.12.1 Sanofi SA Company Details
  • 10.12.2 Sanofi SA Business Overview and Its Total Revenue
  • 10.12.3 Sanofi SA Influenza Therapeutics Introduction
  • 10.12.4 Sanofi SA Revenue in Influenza Therapeutics Business (2015-2020)
  • 10.12.5 Sanofi SA Recent Development
• 13.13 Shionogi & Co., Ltd.
  • 10.13.1 Shionogi & Co., Ltd. Company Details
  • 10.13.2 Shionogi & Co., Ltd. Business Overview and Its Total Revenue
  • 10.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Introduction
  • 10.13.4 Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
  • 10.13.5 Shionogi & Co., Ltd. Recent Development
• 13.14 Sinovac Biotech Ltd.
  • 10.14.1 Sinovac Biotech Ltd. Company Details
  • 10.14.2 Sinovac Biotech Ltd. Business Overview and Its Total Revenue
  • 10.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Introduction
  • 10.14.4 Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
  • 10.14.5 Sinovac Biotech Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer